Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Health
|
Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
|
Policies or Program
|
Budget,
Economic Development,
Federal-Provincial Relations,
Health
|
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
|
Policies or Program
|
Budget,
Federal-Provincial Relations,
Health
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
|
Policies or Program
|
Budget,
Health
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
Economic Development,
Health,
Intellectual Property
|
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
|
Policies or Program
|
Federal-Provincial Relations,
Health
|
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
|
Regulation
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
|
Regulation
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Date | DPOH, Position Title | Government Institution | Subject Matters |
---|---|---|
2024-06-20 |
|
Health |
2024-06-19 |
|
Health |